» Articles » PMID: 35330056

The Differential Prognostic Impact of Long-Duration Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices Between Patients with and Without a History of Atrial Fibrillation

Abstract

Long-duration atrial high-rate episodes (AHREs) monitored using cardiac implantable electronic devices (CIEDs) can predict long-term major adverse cardiovascular events (MACEs). This study aimed to compare the impact of long-duration AHRE on MACE development between patients with and without a history of atrial fibrillation (AF). This single-center observational study included 132 CIED-implanted patients with AHREs detected via remote monitoring. The population was dichotomized into groups: with (n = 69) and without (n = 63) AF. In each group, cumulative incidences of MACEs comprising all-cause deaths, heart failure hospitalizations, strokes, and acute coronary syndromes were compared between patients with AHRE durations of ≥24 h and <24 h. Multivariate analysis was performed to identify predictors of MACEs among patients without AF. MACE incidence was significantly higher in patients with AHRE ≥24 h than in those with <24 h in the group without AF (92% vs. 30%, p = 0.005). MACE incidence did not significantly differ between AHRE ≥24 h and <24 h in the group with AF (54% vs. 26%, p = 0.44). After a multivariate adjustment, AHRE duration of ≥24 h emerged as the only independent predictor of MACEs among patients without AF (p = 0.03). In conclusion, a long-duration AHRE was prognostic in patients without a history of AF but not in patients with a history of AHREs.

Citing Articles

Is there any difference in the therapeutic effects of Levosimendan on advanced HFrEF patients with sinus rhythm or atrial fibrillation?.

Wang W, Li F, Huang H, Wu X, Tian W, Yu T Front Cardiovasc Med. 2023; 10:1084300.

PMID: 36910542 PMC: 9995919. DOI: 10.3389/fcvm.2023.1084300.

References
1.
Santhanakrishnan R, Wang N, Larson M, Magnani J, McManus D, Lubitz S . Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction. Circulation. 2016; 133(5):484-92. PMC: 4738087. DOI: 10.1161/CIRCULATIONAHA.115.018614. View

2.
Ogino Y, Ishikawa T, Ishigami T, Matsumoto K, Hosoda J, Iguchi K . Characteristics and Prognosis of Pacemaker-Identified New-Onset Atrial Fibrillation in Japanese People. Circ J. 2017; 81(6):794-798. DOI: 10.1253/circj.CJ-16-1018. View

3.
Crossley G, Chen J, Choucair W, Cohen T, Gohn D, Ben Johnson W . Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers. J Am Coll Cardiol. 2009; 54(22):2012-9. DOI: 10.1016/j.jacc.2009.10.001. View

4.
Pozzoli M, Cioffi G, Traversi E, Pinna G, Cobelli F, Tavazzi L . Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol. 1998; 32(1):197-204. DOI: 10.1016/s0735-1097(98)00221-6. View

5.
Jabre P, Roger V, Murad M, Chamberlain A, Prokop L, Adnet F . Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation. 2011; 123(15):1587-93. PMC: 3082773. DOI: 10.1161/CIRCULATIONAHA.110.986661. View